Phase 3 Trial
Clinical Trials
A Phase 3 trial is the large, often pivotal study — typically hundreds to thousands of patients — designed to confirm efficacy and safety against a control. Positive Phase 3 topline data is usually the key evidence supporting an FDA filing.
Related terms
Learn more
Phase 3 Readouts calendar — Track upcoming Phase 3 clinical trial top-line data readouts for biotech companies. Pivotal trial results calendar.Phase 3 Trial Endpoints Explained: P-Values, Hazard Ratios, and What Investors Need to KnowBiotech Clinical Trial Phases Explained: What Investors Need to Know
Track Phase 3 Trial across 1,000+ biotechs
BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.
Start Free